Anti-alzheimer Disease Compound Library
Catalog No.L5900
Offered in 96 or 384 well plate format

A unique collection of 485 small molecules for exploring the mechanism of alzheimer's disease.
Selleck Chemicals compound library contributes and expedites
the investigation of treatments against COVID19
The researchers at the National Institute of Infectious Diseases, in Japan, successfully found anti-COVID19 drugs within 3 months of
screening FDA-approved drug library from Selleck Chemicals. They have already published this article doi: 10.1101/2020.04.14.039925.
You Could Select:
Anti-alzheimer Disease Compound Library Contents
Description & Advantages
•A unique collection of 485 small molecules for for high throughput screening (HTS) and high content screening (HCS)
•Targets BACE,γ-Secretase,5-HT Receptor,Dopamine Receptor,Adenosine Receptor,etc
•Used for exploring the mechanism of alzheimer's disease and looking for new treatments
•Structurally diverse, medicinally active, and cell permeable
•Rich documentation with structure, IC50, and customer reviews
•NMR and HPLC validated to ensure high purity
Product Details
Formulation: | 451 compounds pre-dissolved in 10mM DMSO, 21 compounds pre-dissolved in 10mM water, 11 compounds pre-dissolved in 2mM DMSO and 2 compounds pre-dissolved in 2mM water |
---|---|
Container: | 96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode |
Stability: | in DMSO |
in DMSO | |
Shipping: | Blue ice or dry ice |